Table 2 . Deficiencies that enhance or suppress X NDJ of X/X;bubR1D1326N/bubR1rev1 females.
| Cytogenetic Breakpoints | Normal ProgenyX/XY and X/O | Exceptional Progeny | Total Adjusted Progeny | Δ With Matched Controla | Δ With Average Controlb | ||||
|---|---|---|---|---|---|---|---|---|---|
| Deficiency Name | XX/O | O/XY | X NDJ | Candidate | |||||
| Enhancer deficiencies | |||||||||
| Df(3L)BSC23 | 62E8;63B5-6 | 550 | 127 | 16 | 836 | 34.21%c | 14.70% | 8.39% | Mrtf; aly |
| Df(3L)BSC13 | 66B12-C1;66D2-4 | 841 | 281 | 14 | 1431 | 41.23%c | 18.24% | 15.41% | mtrm |
| Df(3L)Pc-2q | 78C5-6;78E3-79A1 | 323 | 109 | 15 | 571 | 43.43%c | 18.43% | 17.61% | pzg; Pc; SAK |
| Df(3R)ED5177 | 83B4;83B6 | 462 | 105 | 16 | 704 | 34.38%c | 9.84% | 8.56% | asl |
| Df(3R)ED5780 | 89E11;90C1 | 61 | 22 | 4 | 113 | 46.02%c | 17.16% | 20.20% | cal1; ald |
| Df(3R)D605 | 97E2;98A3-4 | 274 | 85 | 15 | 474 | 42.19%c | 17.19% | 16.37% | Klp98A |
| Suppressor deficiencies | |||||||||
| Df(3L)pbl-X1 | 65F6;66B7-8 | 780 | 30 | 19 | 878 | 11.16%c | −11.83% | −14.66% | Pdp1;pbl; Arp66B |
| Df(3L)ZP1 | 66A17-20;66C1-5 | 968 | 81 | 21 | 1172 | 17.41%c | −5.58% | −8.41% | pbl; Arp66B |
| Df(3L)BSC8 | 74D3-75A1;75B2-5 | 687 | 56 | 17 | 833 | 17.53%c | −7.01% | −8.29% | CycT |
| Df(3L)ED4858 | 76D3;77C1 | 566 | 23 | 13 | 638 | 11.29%c | −17.58% | −14.53% | polo |
| Df(3L)rdgC-co2 | 77A1;77D1 | 686 | 37 | 11 | 782 | 12.28%c | −14.68% | −13.54% | polo |
| Df(3L)ED4978 | 78D5;79A2 | 1712 | 69 | 27 | 1904 | 10.08%c | −6.52% | −15.74% | |
| Df(3L)Ten-m-AL29 | 79C1-3;79E3-8 | 1079 | 64 | 19 | 1245 | 13.33%c | −6.17% | −12.49% | |
| Df(3R)Tpl10 | 83C1-2;84B1-2, 83D4-5;84A4-5;98F1-2 | 647 | 20 | 22 | 731 | 11.49%c | −8.02% | −14.33% | bcd |
| Df(3R)GB104 | 85D12;85E10 | 189 | 2 | 1 | 195 | 3.08%c | −13.52% | −22.74% | βTub85D; hyd; αTub85E; topi |
| Df(3R)ED5559 | 86E11;87B11 | 270 | 0 | 0 | 270 | 0.00%c | −21.34% | −25.82% | aur; ssp5 |
| Df(3R)sbd105 | 88F9-89A1;89B9-10 | 1022 | 106 | 23 | 1280 | 20.16%c | −15.05% | −5.66% | c(3)G; msps |
| Df(3R)ED5942 | 91F12;92B3 | 725 | 78 | 18 | 917 | 20.94%c | −6.47% | −4.88% | |
| Df(3R)BSC55 | 94D2-10;94E1-6 | 613 | 43 | 20 | 739 | 17.05%c | −10.36% | −8.77% | sav |
| Df(3R)mbc-30 | 95A5-7;95C10-11 | 181 | 8 | 1 | 199 | 9.05%c | −18.37% | −16.77% | Rpn9; eIF4G2; Pros26.4; CG13599; SMC1 |
| Df(3R)mbc-R1 | 95A5-7;95D6-11 | 1302 | 32 | 49 | 1464 | 11.07%c | −20.22% | −14.75% | Rpn9; eIF4G2; Pros26.4; CG13599; SMC1 |
| Df(3R)Exel6202 | 96D1;96D1 | 837 | 64 | 29 | 1023 | 18.18%c | −10.68% | −7.64% | |
| Df(3R)BSC42 | 98B1-2;98B3-5 | 1849 | 126 | 35 | 2171 | 14.83%c | −16.45% | −10.99% | Sce; btz |
| Df(3R)3450 | 98E3;99A6-8 | 1003 | 42 | 28 | 1143 | 12.25%c | −7.26% | −13.57% | Doa; Slu7; yemaα; dgt6; Slbp; stg |
a
Difference between X NDJ of the deficiency-bearing flies vs. matched control.
b
Difference between X NDJ of the deficiency-bearing flies vs. average controls.
c
The percentage of X NDJ is significantly higher/lower than in X/X;bubR1D1326N/bubR1rev1 females (multinomial-Poisson hierarchy model, P < 0.05).